Working… Menu
Trial record 7 of 42 for:    FROVATRIPTAN

A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00821483
Recruitment Status : Completed
First Posted : January 13, 2009
Last Update Posted : April 18, 2013
Information provided by (Responsible Party):
SK Chemicals Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 2008
Actual Study Completion Date : February 2008